Our findings are consistent with a study in JIA and IBD patients, showing a reduced functionality of antibodies and a lower proportion of protecting antibodies against serogroup W following MenACWY vaccination; differences in that study were especially pronounced in anti-TNF users [13]. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.